Pravachol and C. diff - a phase IV clinical study of FDA data

Summary:

C. diff is reported as a side effect among people who take Pravachol (pravastatin sodium), especially for people who are female, 60+ old, also take Celexa, and have Sleep apnea syndrome.

The phase IV clinical study analyzes which people have C. diff when taking Pravachol. It is created by eHealthMe based on reports of 23,862 people who have side effects when taking Pravachol from the FDA, and is updated regularly.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.

What is C. diff?

C. diff is found to be associated with 1,574 drugs and 1,776 conditions by eHealthMe. Check the latest studies of C. diff.

On Jun, 12, 2026

23,862 people reported to have side effects when taking Pravachol.
Among them, 35 people (0.15%) have C. diff.

Among these 35 people:

What is the gender of people who have C. diff when taking Pravachol? *

female: 74.29 %
male: 25.71 %

What is the age of people who have C. diff when taking Pravachol? *

What are other drugs people take besides Pravachol? *

What are other side effects people have besides C. diff? *

Dyspnea (difficult or laboured breathing): 22 people, 62.86%
Fatigue (feeling of tiredness): 21 people, 60.00%
Nausea And Vomiting: 19 people, 54.29%
Diarrhea: 19 people, 54.29%
Depression: 19 people, 54.29%
Pain: 18 people, 51.43%
Dehydration (dryness resulting from the removal of water): 18 people, 51.43%
Fever: 18 people, 51.43%
Stress And Anxiety: 18 people, 51.43%
Muscle Spasms (muscle contraction): 17 people, 48.57%

What are the existing conditions these people have? *

Sleep Apnea Syndrome: 14 people, 40.00%
Metastases To Bone (cancer spreads to bone): 6 people, 17.14%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 11.43%
Bone Density Decreased: 4 people, 11.43%
Bone Loss: 4 people, 11.43%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 3 people, 8.57%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 3 people, 8.57%
Chest Pain: 3 people, 8.57%
Dupuytren's Contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers): 3 people, 8.57%
Pain: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Pravachol and have C. diff?

- Check whether C. diff is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pravachol:

Pravachol (24,382 reports)

C. diff treatments and more:

C. diff (13,845 reports)

Browse all side effects of Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with C. diff:

C. diff (1,574 drugs)

Browse all the conditions that are associated with C. diff:

C. diff (1,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pravastatin sodium (the active ingredients of Pravachol) and Pravachol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.